Research programme: glycine transporter 2 inhibitors - OrganonAlternative Names: glycine transporter 2 inhibitors research programme - Organon; GlyT-2 inhibitors research programme - Organon
Latest Information Update: 25 Sep 2006
At a glance
- Originator Organon
- Mechanism of Action Glycine antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 22 Sep 2006 No development reported - Preclinical for Neuropathic pain in United Kingdom (unspecified route)
- 19 Apr 2002 Preclinical trials in Neuropathic pain in United Kingdom (unspecified route)